KPRX Financials
Kiora Pharmaceuticals Inc - Financial statements & key metrics
Stock Price
$2.52
Market Cap
$10.93M
EPS
$-2.64
Income Statement Highlights
Most Recent Quarter: 2025-12-31
Revenue
$0.00
Gross Profit
$-24801.00
Operating Income
$-9.46M
Net Income
$-10.84M
EPS (Diluted)
$-
Balance Sheet Highlights
Total Assets
$24.25M
Total Liabilities
$8.13M
Shareholders Equity
$16.13M
Cash & Equivalents
$8.70M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-9.96M
CapEx
$110789
Free Cash Flow
$-10.07M
Profitability Metrics
ROE
-0.5%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is KPRX revenue?
KPRX's most recent quarterly revenue was $0.00. Annual revenue can be calculated by summing the four most recent quarters.
Is KPRX profitable?
KPRX reported a loss of $10.84M in the most recent quarter.
What is KPRX market cap?
KPRX has a market capitalization of $10.93M, making it a small-cap stock.
Does KPRX have debt?
View KPRX's balance sheet for debt information.
What is KPRX cash flow?
KPRX's most recent quarterly free cash flow was $-10.07M.